Affiliation:
1. Department of Otolaryngology–Head and Neck Surgery University of California, Irvine Medical Center Orange California USA
2. Frank H. Netter MD School of Medicine at Quinnipiac University North Haven Connecticut USA
3. Department of Surgery (Division of Otolaryngology) Yale School of Medicine New Haven Connecticut USA
Abstract
AbstractObjectiveTo determine whether certain groups of otolaryngologists (ORLs) are treating cohorts of patients with more comorbidities.Study DesignCross‐sectional population‐based analysis.Setting2019 Medicare Provider Utilization and Payment Dataset.MethodsEach ORL's average Medicare hierarchical condition category (HCC) risk score, a comorbidity index calculated from a patient's comorbidities, was collected. These were stratified and compared by various physician characteristics, including practice region and rurality, years in practice, gender, subspecialty, and setting (academic vs community).ResultsAmong 8959 ORLs, the mean HCC risk score for Medicare patients was 1.35 ± 0.35. On univariate analysis, ORLs practicing in urban (compared to rural), ORLs in academic settings (compared to community), and early career ORLs all had a patient population with a higher HCC risk score (P < .001 for all). On multivariate analysis controlling for gender, rurality, graduation year, and region, rural setting was associated with decreased odds of having a high‐risk patient population (odds ratio: 0.58 [95% confidence interval, CI: 0.48‐0.71]; P < .001), while those more recently graduated has an increased risk (2000‐2009: 1.41 [1.01‐1.96], P = .046; 2010‐2015: 2.30 [1.63‐3.25], P < .001). In a separate subgroup analysis, subspecialty differences were seen and community setting was associated with decreased odds of having a high‐risk patient population (0.36 [0.23‐0.55]; P < .001).ConclusionThere is variability in patient comorbidity profiles among ORLs, with those in urban settings, those more recently graduated, and those in academic settings treating a group with more comorbidities. As the comorbidity burden may increase the cost of practice and complications, these findings may have important implications for health inequity.